Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Total Non-current Liabilities
All obligations due after more than one year.
Shoulder Innovations, Inc.NYSE: SI
Total Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total non-current liabilities falls 4.7% from a year ago
Total non-current liabilities stood at $14.96M at the end of Q1 FY2026, down 4.7% from a year earlier and down 0.0% from the prior quarter.
Context
- Total non-current liabilities amounted to 9.3% of total assets at the end of Q1 FY2026, down 18.0 pp from a year earlier.
- Total non-current liabilities increased in 1 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether total non-current liabilities keeps falling in the next quarterly balance sheet after a -4.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 14.96M USD
- Year-over-year change
- -83.4%
- 2-year CAGR
- -59.2%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 14.96M | -83.4% |
| FY2024 | 2024-12-31 | 90.13M | +0.4% |
| FY2023 | 2023-12-31 | 89.75M | — |
Total Non-current Liabilities vs competitors
How SI compares with its peers on the latest reported figures
- SI's Mar 2026 total non-current liabilities of $14.96M is the 7th highest of the 11 companies compared; the peer median is $20.99M.
- Its year-over-year change of -4.7% is the 5th highest of 10, against a peer median of -7.6%.
- Total non-current liabilities amounts to 9.3% of total assets for SI, versus a peer median of 14.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $151.67M | -17.3% | +78.5% | 48.2% | |
| Jun 2026 | $125.09M | +24.7% | +6.5% | 94.7% | |
| Mar 2026 | $100.16M | +3.1% | -0.7% | 40.2% | |
| Mar 2026 | $41.57M | -7.6% | +0.4% | 14.5% | |
| Mar 2026 | $25.02M | -0.3% | -2.6% | 14.1% | |
| Mar 2026 | $16.96M | +1828.9% | +199.1% | 45.7% | |
| Mar 2026 | $14.96M | -4.7% | — | 9.3% | |
| Dec 2025 | $5.54M | -19.8% | -23.1% | 3.4% | |
| Mar 2026 | $1.9M | -92.5% | -10.1% | 0.8% | |
EPRXEupraxia Pharmaceuticals Inc. | Mar 2026 | $1.81M | — | -81.5% | 1.2% |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding SI) | $20.99M | -7.6% | -0.7% | 14.3% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.